Sectors
MGNX
MacroGenics, Inc.
4.05
5 x 2.96
6 x 5.15
bid
ask
-
0.08
1.82%
10:29 AM
timesize
| Ytd | 151.86% | |
| 1y | 129.10% |
4.00
day range
4.13
1.29
52 week range
5.08
| Open | 4.12 | Prev Close | 4.13 | Low | 4.00 | High | 4.13 | Mkt Cap | 258.30M |
| Vol | 83.31K | Avg Vol | 857.33K | EPS | -1.59 | P/E | N/A | Forward P/E | -1.34 |
| Beta | 1.20 | Short Ratio | 7.20 | Inst. Own | 93.63% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 4.24 | 200-d Avg | 2.96 | 1yr Est | 7.38 |
| Income Statement | |||
| Total Revenue | 32.83M | ||
| Revenues (USD) | 32.83M | ||
| Gross Profit | 32.83M | ||
| Operating Expenses | 46.68M | ||
| Research and Development Expense | 38.78M | ||
| Selling, General and Administrative Expense | 7.90M | ||
| Operating Income | -13.85M | ||
| Interest Expense | 4.40M | ||
| Net Income | 19.52M | ||
| Net Income Common Stock | 19.52M | ||
| Net Income Common Stock (USD) | 19.52M | ||
| Consolidated Income | 19.52M | ||
| Net Income from Discontinued Operations | -89.16M | ||
| Earnings per Basic Share | 0.31 | ||
| Earnings per Basic Share (USD) | 0.31 | ||
| Earnings per Diluted Share | 0.31 | ||
| Earning Before Interest & Taxes (EBIT) | 23.91M | ||
| Earning Before Interest & Taxes (USD) | 23.91M | ||
| Weighted Average Shares | 63.59M | ||
| Weighted Average Shares Diluted | 63.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 113.91M | ||
| Cash and Equivalents (USD) | 113.91M | ||
| Investments | 59.40M | ||
| Investments Current | 59.40M | ||
| Trade and Non-Trade Receivables | 144.17M | ||
| Current Assets | 321.69M | ||
| Property, Plant & Equipment Net | 23.53M | ||
| Total Assets | 345.41M | ||
| Debt Current | 19.97M | ||
| Total Debt | 213.24M | ||
| Current Liabilities | 108.82M | ||
| Debt Non-Current | 193.27M | ||
| Total Liabilities | 302.54M | ||
| Accumulated Retained Earnings (Deficit) | -1.26B | ||
| Accumulated Other Comprehensive Income | -15.00K | ||
| Shareholders Equity | 42.87M | ||
| Shareholders Equity (USD) | 42.87M | ||
| Assets Non-Current | 23.72M | ||
| Total Debt (USD) | 213.24M | ||
| Deferred Revenue | 55.50M | ||
| Liabilities Non-Current | 193.72M | ||
| Trade and Non-Trade Payables | 3.44M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000.00K | ||
| Net Cash Flow from Financing | 60.17M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 47.39M | ||
| Capital Expenditure | -806.00K | ||
| Issuance (Purchase) of Equity Shares | 173.00K | ||
| Issuance (Repayment) of Debt Securities | 60.00M | ||
| Net Cash Flow from Investing | 27.97M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 28.77M | ||
| Net Cash Flow from Operations | -40.75M | ||
| Share Based Compensation | 1.97M | ||